The study of tumor related macrophages in retinoblastoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041177

Enrollment

Unknown

Registered

2020-12-20

Start date

2020-12-31

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinoblastoma

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed with retinoblastoma; 2. Clear indication of enucleation and the patient's legal guardian agrees to enucleation.

Exclusion criteria

Exclusion criteria: 1. Patient who have recently received immunoregulatory treatment; 2. Patients who do not have clear indications for surgery, or have indications for surgery but are not willing to undergo surgery by their legal guardians; 3. Patients with other immune diseases.

Design outcomes

Primary

Measure	Time frame
cell density;inflammatory factor;	—

Countries

China

Contacts

Public ContactHongfeng Yuan

Army Medical Center of PLA

yhf871@sina.cn+86 13038316313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026